Items 1 to 10 of 13 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Eltrombopag | 496775-61-2 | sc-207614 sc-207614A sc-207614B | 5 mg 50 mg 100 mg | $263.00 $381.00 $490.00 | 1 | |
Eltrombopag acts as a potent c-mpl receptor agonist, engaging in specific molecular interactions that enhance thrombopoietin signaling. By stabilizing the receptor's active conformation, it promotes the recruitment of downstream signaling molecules, thereby amplifying the JAK-STAT pathway. This modulation of receptor dynamics influences gene expression related to hematopoiesis, showcasing its role in fine-tuning cellular responses within the hematopoietic niche. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine could downregulate c-Mpl by inducing demethylation of its gene promoter, which might silence gene expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
5-Aza-2′-Deoxycytidine (Decitabine) may decrease c-Mpl levels by specifically targeting hypermethylated CpG islands within the MPL gene, leading to transcriptional inactivation. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Suberoylanilide Hydroxamic Acid (Vorinostat) is hypothesized to reduce c-Mpl expression by preventing deacetylation of histones, thus maintaining a chromatin structure not conducive to gene transcription. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A may decrease c-Mpl expression through the inhibition of histone deacetylases, resulting in a histone acetylation pattern that represses the MPL gene. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid could reduce c-Mpl expression by binding to retinoic acid receptors that heterodimerize with repressor proteins at the MPL gene's regulatory regions. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin might inhibit c-Mpl expression by halting the mTOR signaling pathway, which is essential for the translation of certain transcripts including those related to c-Mpl. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is thought to decrease c-Mpl levels by blocking PI3K, an upstream activator of AKT signaling, which is critical for the transcription of growth-related genes. | ||||||
Bromocriptine | 25614-03-3 | sc-337602A sc-337602B sc-337602 | 10 mg 100 mg 1 g | $56.00 $260.00 $556.00 | 4 | |
This dopamine agonist has been investigated for its potential to activate c-Mpl and stimulate platelet production, particularly in cases of thrombocytopenia. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 could inhibit c-Mpl expression by preventing JNK-mediated phosphorylation of transcription factors that directly promote the MPL gene's transcription. | ||||||